Democracy Now: Report: Payments to Settle Fraud by U.S. Drugmakers Have Doubled in 2012

A new report finds U.S. drugmakers have paid $6.6 billion dollars in penalties and fees to settle fraud allegations this year, already doubling what they paid last year. The advocacy group Public Citizen said the increased fees and penalties are still not enough to make a dent in drug company profits or to curb alleged behavior ranging from overcharging Medicare to encouraging the prescription of drugs for unsanctioned uses. In July, GlaxoSmithKline settled for a record $3 billion over fraud charges, including allegations it failed to report key safety data on a diabetes drug linked to heart risks.

~ by wheresthemic on September 28, 2012.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: